8-KThe WireRoutine
Bylaw Amendment
Filed Mar 2, 2026 · 3mo ago · Accession 0001193125-26-085780
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Generate Biomedicines, Inc.
- Ticker
- GENB
- CIK
- 2100782
- Form type
- 8-K
- Filing date
- Mar 2, 2026
- Report date
- Feb 26, 2026
- Document
- ck0002100782-20260226.htm
- Size
- 468 KB